Key Record Dates
ClinicalTrials.gov Identifier: | NCT02872025 |
---|---|
Brief Title: | Pembrolizumab in High-risk Ductal Carcinoma in Situ (DCIS) |
First Submitted : | August 10, 2016 |
First Submitted that Met QC Criteria : | August 15, 2016 |
First Posted : | August 18, 2016 (Estimate) |
Last Update Submitted that Met QC Criteria : | October 21, 2022 |
Last Update Posted : | October 25, 2022 |